Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases

被引：28

作者：

Sharma, Vinesh ^{[1
,2
]}

Patial, Vikram ^{[1
,2
]}

机构：

[1] Inst Himalayan Bioresource Technol, Dietet & Nutr Technol Div, Pharmacol & Toxicol Lab, CSIR, Palampur, HP, India

[2] Acad Sci & Innovat Res AcSIR, Ghaziabad, UP, India

来源：

FRONTIERS IN PHARMACOLOGY | 2022年 / 13卷

关键词：

kidney diseases; natural agonists; PPAR-gamma; synthetic agonists; pathophysiology; ZHEN-WU-TANG; PPAR-GAMMA; DIABETIC-NEPHROPATHY; OXIDATIVE STRESS; IGA NEPHROPATHY; METABOLIC SYNDROME; INJURY; SUPPLEMENTATION; HYPERTENSION; INFLAMMATION;

D O I：

10.3389/fphar.2022.991059

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Kidney disease is one of the leading non-communicable diseases related to tremendous health and economic burden globally. Diabetes, hypertension, obesity and cardiovascular conditions are the major risk factors for kidney disease, followed by infections, toxicity and autoimmune causes. The peroxisome proliferator-activated receptor gamma (PPAR-gamma) is a ligand-activated nuclear receptor that plays an essential role in kidney physiology and disease. The synthetic agonists of PPAR-gamma shows a therapeutic effect in various kidney conditions; however, the associated side effect restricts their use. Therefore, there is an increasing interest in exploring natural products with PPAR gamma-activating potential, which can be a promising solution to developing effective and safe treatment of kidney diseases. In this review, we have discussed the role of PPAR-gamma in the pathophysiology of kidney disease and the potential of natural PPAR-gamma agonists in treating various kidney diseases, including acute kidney injury, diabetic kidney disease, obesity-induced nephropathy, hypertension nephropathy and IgA nephropathy. PPAR-gamma is a potential target for the natural PPAR-gamma agonists against kidney disease; however, more studies are required in this direction.

引用

页数：18

共 94 条

[1] Beneficial effects of PPAR-γ ligands in ischemia-reperfusion injury, inflammation and shock [J].

Abdelrahman, M ;

Sivarajah, A ;

Thiemermann, C .

CARDIOVASCULAR RESEARCH, 2005, 65 (04) :772-781

[2] Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity [J].

AL-Suhaimi, Ebtesam A. ;

Shehzad, Adeeb .

EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2013, 18

[3] Resveratrol supplementation improves white adipose tissue function in a depot-specific manner in Zucker diabetic fatty rats [J].

Beaudoin, Marie-Soleil ;

Snook, Laelie A. ;

Arkell, Alicia M. ;

Simpson, Jeremy A. ;

Holloway, Graham P. ;

Wright, David C. .

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2013, 305 (05) :R542-R551

[4] Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity [J].

Benson, SC ;

Pershadsingh, HA ;

Ho, CI ;

Chittiboyina, A ;

Desai, P ;

Pravenec, M ;

Qi, NN ;

Wang, JM ;

Avery, MA ;

Kurtz, TW .

HYPERTENSION, 2004, 43 (05) :993-1002

[5] Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J].

Bikbov, Boris ;

Purcell, Carrie ;

Levey, Andrew S. ;

Smith, Mari ;

Abdoli, Amir ;

Abebe, Molla ;

Adebayo, Oladimeji M. ;

Afarideh, Mohsen ;

Agarwal, Sanjay Kumar ;

Agudelo-Botero, Marcela ;

Ahmadian, Elham ;

Al-Aly, Ziyad ;

Alipour, Vahid ;

Almasi-Hashiani, Amir ;

Al-Raddadi, Rajaa M. ;

Alvis-Guzman, Nelson ;

Amini, Saeed ;

Andrei, Tudorel ;

Andrei, Catalina Liliana ;

Andualem, Zewudu ;

Anjomshoa, Mina ;

Arabloo, Jalal ;

Ashagre, Alebachew Fasil ;

Asmelash, Daniel ;

Ataro, Zerihun ;

Atout, Maha Moh'd Wahbi ;

Ayanore, Martin Amogre ;

Badawi, Alaa ;

Bakhtiari, Ahad ;

Ballew, Shoshana H. ;

Balouchi, Abbas ;

Banach, Maciej ;

Barquera, Simon ;

Basu, Sanjay ;

Bayih, Mulat Tirfie ;

Bedi, Neeraj ;

Bello, Aminu K. ;

Bensenor, Isabela M. ;

Bijani, Ali ;

Boloor, Archith ;

Borzi, Antonio M. ;

Camera, Luis Alberto ;

Carrero, Juan J. ;

Carvalho, Felix ;

Castro, Franz ;

Catala-Lopez, Ferran ;

Chang, Alex R. ;

Chin, Ken Lee ;

Chung, Sheng-Chia ;

Cirillo, Massimo .

LANCET, 2020, 395 (10225) :709-733

[6] The use of green tea polyphenols for treating residual albuminuria in diabetic nephropathy: A double-blind randomised clinical trial [J].

Borges, Cynthia M. ;

Papadimitriou, Alexandros ;

Duarte, Diego A. ;

de Faria, Jacqueline M. Lopes ;

de Faria, Jose B. Lopes .

SCIENTIFIC REPORTS, 2016, 6

[7] The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice [J].

Bose, Mousumi ;

Lambert, Joshua D. ;

Ju, Jihyeung ;

Reuhl, Kenneth R. ;

Shapses, Sue A. ;

Yang, Chung S. .

JOURNAL OF NUTRITION, 2008, 138 (09) :1677-1683

[8] Zhen-wu-tang, a blended traditional Chinese herbal medicine, ameliorates proteinuria and renal damage of streptozotocin-induced diabetic nephropathy in rats [J].

Cai, Yu ;

Chen, JianWen ;

Jiang, JianMin ;

Cao, Weiwei ;

He, Lan .

JOURNAL OF ETHNOPHARMACOLOGY, 2010, 131 (01) :88-94

[9] The Effect of Resveratrol and Quercetin Treatment on PPAR Mediated Uncoupling Protein (UCP-) 1, 2, and 3 Expression in Visceral White Adipose Tissue from Metabolic Syndrome Rats [J].

Castrejon-Tellez, Vicente ;

Manuel Rodriguez-Perez, Jose ;

Perez-Torres, Israel ;

Perez-Hernandez, Nonanzit ;

Cruz-Lagunas, Alfredo ;

Guarner-Lans, Veronica ;

Vargas-Alarcon, Gilberto ;

Esther Rubio-Ruiz, Maria .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (07)

[10] IgA Nephropathy in India: What We Do Know [J].

Chacko, Bobby .

RENAL FAILURE, 2011, 33 (01) :102-107

← 1 2 3 4 5 6 7 8 9 10 →